Genetic Screening & Testing
Genetic Screening & Testing
Genetic screening and testing are powerful tools. They identify those who are at increased risk for cancer, allowing for earlier interventions to prevent disease, and they guide the development of customized treatments based on each patient’s unique genetic makeup and mutations.
Florida Cancer Specialists & Research Institute (FCS) has robust genetic screening, counseling and testing capabilities available for patients.
We can inherit genetic mutations from our parents that put us at increased risk of developing certain cancers. Knowing risk factors for hereditary cancers early can be lifesaving, allowing patients to choose early screening and preventative treatments to decrease their risk of disease.
Supported by the latest technology, our specially trained genetics specialist is able to identify those who are at high-risk. Individuals can be referred for consultation and genetic testing or receive guidance to make lifestyle changes or explore other preventive options to reduce future risk.
Facts About Genetic Screening:
What can I expect when I meet with an FCS cancer expert?
Your personal and family cancer history will be reviewed, including type(s) of cancer and age(s) at diagnosis. Based on this information, a genetics professional will evaluate your risk of inherited cancer and discuss available genetic testing.
In a visit referred to as a genetic counseling session, they will discuss the benefits and considerations to help you decide if genetic testing is right for you. Topics covered in the discussion include:
- The process for ordering genetic testing
- Insurance coverage
- The emotional impact of the information on you and your family
- Medical management options based on your family history and/or genetic test results.
For genetic counseling inquiries, email: GeneticCounselor@FLCancer.com
Our state-of-the-art FCS Laboratory is equipped to provide next generation sequencing (NGS) clinical testing on solid tumors and hematologic malignancies. Information gained through genetic testing can be used to personalize therapy — increasing cure rates and extending lives.
NGS testing allows geneticists to detect mutations in hundreds of different genes simultaneously, giving a more unique understanding of each patient’s individual diagnosis. When oncologists know the specific genetic alteration a patient has, there may be a therapy that actually targets that exact mutation, as well as ongoing clinical trials the patient would be eligible for based on his/her molecular profile.
FCS continues to expand our robust in-house testing capabilities, so that we can provide our patients with fast and accurate diagnosis and treatment planning, which leads to more positive outcomes.
For FCS molecular testing inquiries, email: MolecularTesting@FLCancer.com